Zohar Biron-Sorek

Zohar Biron-Sorek has a strong background in protein engineering, target discovery, and molecular biology. With experience in leading teams in various companies such as Ukko, Picodya Tec., Glusense, and Proteologics Ltd, Zohar has successfully managed projects focused on developing medical devices and drug discovery processes. Their expertise also includes working on the development of vaccines for diseases like HIV during their time at Novartis (formerly Chiron). Zohar holds a Doctor of Philosophy (PhD) degree in Biotechnology from the Weizmann Institute of Science.